ARTL
ARTELO BIOSCIENCES, INC.
+0.19 (+5.04%)3.94USD94.2K成交股數18.1M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 876K | 773K | 893K | 1.3M | 1.9M | 1.4M | 325K | 1.7M | 1.5M | 2.1M | 1.6M | 752K |
| 銷售管理費用 | 1.6M | 1.9M | 1.9M | 1.8M | 1.3M | 995K | 870K | 827K | 1.1M | 1.1M | 1.0M | 1.0M |
| 營業利益 | −2.5M-20% | −2.7M+13% | −2.8M+133% | −3.1M+23% | −3.2M+22% | −2.4M-27% | −1.2M-54% | −2.5M+41% | −2.6M | −3.2M | −2.6M | −1.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −2.4M-25% | −3.0M+25% | −4.2M+268% | −3.1M+28% | −3.2M+30% | −2.4M-23% | −1.1M-54% | −2.4M+52% | −2.5M | −3.1M | −2.4M | −1.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.89-95% | -4.00-68% | -4.37+108% | -3.97-12% | -16.86+262% | -12.55 | -2.10+153% | -4.52 | -4.66 | – | -0.83 | – |
| 稀釋股數 | 2.7M | 739K | 343K | 787K | 191K | 189K | 538K | 538K | 533K | 494K | 2.9M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.2M | 4.2M | 600K | 1.7M | 2.1M | 746K | 4.4M | 881K | 1.2M | 2.8M | 2.6M | 5.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 6.5M | 12.5M | 2.8M | 4.3M | 4.4M | 3.5M | 7.1M | 8.3M | 10.4M | 13.0M | 15.5M | 16.9M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.5M | 5.8M | 4.1M | 4.9M | 5.8M | 2.9M | 775K | 1.0M | 817K | 1.3M | 921K | 609K |
| 股東權益 | 5.0M | 6.7M | −1.3M | −633K | −1.4M | 652K | 6.4M | 7.3M | 9.5M | 11.8M | 14.6M | 16.3M |
| 負債比 | 22.6% | 46.7% | 145.4% | 114.8% | 132.3% | 81.5% | 10.9% | 12.3% | 7.9% | 9.9% | 5.9% | 3.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.2M-25% | – | – | – | −1.6M | – | – | −2.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −12.9M | –% | -37.75 | – |
| FY2024 | – | – | −9.8M | –% | -54.89 | – |
| FY2023 | – | – | −9.3M | –% | -18.80 | – |
| FY2022 | – | – | −10.1M | –% | – | – |
| FY2021 | – | – | −9.4M | –% | – | – |
| FY2021 | – | – | −7.4M | –% | -0.40 | – |
| FY2020 | – | – | −4.7M | –% | -1.26 | – |
| FY2019 | – | – | −2.2M | –% | -1.46 | – |